Detection and elimination of calves and cows persistently infected with bovine viral diarrhea virus (BVDV) is important for the control of this pathogen. Historically, BVDV detection involved cell culture isolation followed by virus detection through immunofluorescence or immunoperoxidase monolayer assay (IPMA) methods. More recently, immunohistochemistry (IHC) has been added as a routine test for BVDV detection. The detection of BVDV by gel-based reverse transcription polymerase chain reaction (RT-PCR) is more sensitive and rapid than by cell culture isolation, but test results can be compromised by sample contamination during nucleic acid amplification. This study was designed to develop a closed-tube format of BVDV nucleic acid amplification and detection, TaqMan RT-PCR. The results of this new technique were compared with those obtained with virus isolation, IPMA, and IHC. With TaqMan RT-PCR, BVDV was detected in many samples negative by IPMA, IHC, and virus isolation with the exception of 1 sample that was positive by IHC. TaqMan RT-PCR in a closed-tube format offers a rapid, economical, high volume, and sensitive method for BVDV detection without the concerns of amplified cDNA product contamination associated with open-tube gel-based PCR tests.
Bovine viral diarrhea virus (BVDV) is an important pathogen that has been associated with inapparent infections and a variety of syndromes, such as diarrhea, mucosal disease, abortions, stillbirths, and other reproductive problems. 9 The virus has also been shown to decrease the resistance of infected cattle to other pathogens. 8 BVDV is a member of the family Flaviviridae, genus Pestivirus. The positive sense RNA genome is single stranded and ranges in length from 12.2 to 15.5 kilobases (kb). There are 2 genotypes (types 1 and 2), and each genotype may appear as 2 biotypes (cytopathic or noncytopathic). 6 Infection with noncytopathic BVDV in utero (before 125 days of gestation) may result in a lifelong persistent infection in the fetus. 2, 5 Some of the persistently infected (PI) calves are born weak or small and are known as ''poor doers.'' 5 In general, PI animals lack neutralizing and nonneutralizing antibodies to BVDV or have low levels of these antibodies. 14 When these immunotolerant animals are infected with a different strain of BVDV unrelated to the persisting virus, they develop a fatal condition known as mucosal disease. PI animals are known to shed large amounts of BVDV throughout their lives and thus act as a source of infection for their herdmates. 14 On average, 1-2% of cattle in this country are estimated to be PI, and in some herds this rate can be as high as 9%. 3 Because most PI animals appear healthy but can still act as reservoirs of virus, these animals must be removed from the herd for BVDV control efforts to be successful. 11 Hence, methods are needed that can accurately detect these animals. To ensure that a herd has no PI animals, all cattle in the herd should be screened for the presence of the virus. Virus isolation (VI) from buffy coats followed by confirmation with immunofluorescence is considered to be a reliable method for this purpose. 13 This method was modified recently so that serum samples are used for VI and the samples are inoculated in 96-well microtiter plates followed by confirmation with an immunoperoxidase monolayer assay (IPMA). 5 However, the technique of VI is not very sensitive, and the results are available only after Ն7 days.
Previous work has shown that reverse transcription polymerase chain reaction (RT-PCR) amplification of the 5Ј-untranslated region of BVDV is a reliable alternative to other methods of virus detection. 7, 12 The genome is single-stranded nonpolyadenylated RNA approximately 12.5 kb in length. 4 It contains 1 large open reading frame, which is preceded by a 361-386base untranslated region (UTR). A nested set of degenerate primers designed to target the conserved 3Ј region of the viral genome was used to develop a double PCR. 1 The advantages of an RT-PCR method are that the presence of antibodies in serum samples does not affect the outcome of the test, the test is rapid and sensitive, and the test should detect all BVDV strains. However, gel-based RT-PCR testing is labor intensive.
It is also frequently compromised by the RT-PCR products from the opened tubes of previous amplifications, which may contaminate subsequent RT-PCR reactions. In this study, the TaqMan-based RT-PCR test was used, which incorporates the dual steps of RT-PCR amplification and product detection in a single closed tube, minimizing possible contamination.
Materials and methods
Virus isolates. A cytopathic strain of BVDV propagated in monolayers of bovine turbinate (BT) cells was used to optimize the TaqMan RT-PCR test and to determine test sensitivity for BVDV. This strain was isolated from a cow that died of BVDV infection as confirmed by immunohistochemistry (IHC) and VI from rumen, esophagus, and kidney tissue samples. An isolate of border disease virus of sheep (BDV) was also used. a A bovine respiratory syncytial virus vaccine b and a multivalent vaccine c against infectious bovine rhinotracheitis, parainfluenza virus type 3, and respiratory syncytial virus were used as negative controls in the TaqMan RT-PCR test.
Ten isolates of BVDV from 3 states, obtained over a 5-yr period at the Minnesota Veterinary Diagnostic Laboratory (MVDL), were genotyped at the National Veterinary Services Laboratory in Ames, Iowa. These 10 clinical isolates were used to determine the specificity of the newly developed TaqMan RT-PCR. In addition, 1,416 bovine serum samples submitted to the MVDL over a 1-yr period were tested by 1) BVDV TaqMan RT-PCR, VI, and IPMA (experiment A), 2) BVDV TaqMan RT-PCR and VI (experiment B), or 3) BVDV TaqMan RT-PCR and IPMA (experiment C). Furthermore, 1,035 postmortem tissue samples from cattle were tested by 1) BVDV TaqMan RT-PCR, VI, and IHC (experiment D), 2) BVDV TaqMan RT-PCR and VI (experiment E), or 3) BVDV TaqMan RT-PCR and IHC (experiment F).
Viral RNA isolation. Viral RNA from clinical samples (tissue homogenate and serum) and from BVDV isolates was extracted and purified using a commercial kit according to the manufacturer's protocol. d Viral lysis buffer d (560 l) was added to 140 l of each sample and incubated for 10 min at room temperature for lysis. Ethanol (100%, 560 l) was then added to the lysate, and the mixture was applied to a silica-gel membrane spin column. d After washing the column with wash buffer 1 d and then wash buffer 2, d viral RNA was eluted with 60 l of RNase-free water containing sodium azide. d RNA samples were immediately used in RT-PCR experiments or stored at Ϫ70 C.
TaqMan probe and PCR primer sequences. Forward and reverse primers were made to the 5Ј UTR of BVDV based on primers designed previously. 7 Nucleotide sequences of 126 BVDV strains deposited in GenBank were aligned using a commercial program. e Nucleotide alignment of all available 5Ј UTR sequences suggested that the published PCR primers 7 be modified slightly. As a result, the primers were lengthened and degeneracy was included at specific nucleotide sites to enable them to anneal to a wider range of BVDV strains. These primers (BVDV forward: 5Ј-GGGNAGTCGTCARTGGTTCG-3Ј; BVDV reverse: 5Ј-GTGCCATGTACAGCAGAGWTTTT-3Ј) amplify a fragment of approximately 190 bases in both BVDV type I and BVDV type II.
The BVDV TaqMan probe was also designed using the 126-strain nucleotide alignment and based on the approximately 190 bases of amplified sequence produced by PCR using the primers described above. f Degeneracy was incorporated into the probe to account for the diversity among the strains examined. The probe (5Ј-6-FAM-CCA-YGTGGACGAGGGCAYGC-TAMRA-3Ј) was modified to include a 6-FAM (6-carboxy-fluorescein) fluorescent reporter molecule at the 5Ј end and a TAMRA (6-carboxy-tetramethyl-rhodamine) quencher molecule at the 3Ј end. f One-step TaqMan RT-PCR assay. An RT-PCR assay was developed in which both the RT and PCR utilizing the BVDV-specific primers and probe take place in 1 tube. g RT-PCR analysis was carried out in a total volume of 25 l containing 5 l RNA, 1ϫ RT-PCR buffer (Tris Cl, KCl, (NH 4 ) 2 SO 4 , 12.5 mM MgCl 2 , dithiothreitol; pH 8.7, 20 C), g 1ϫ TaqMan buffer A containing a reference dye ROX, h 0.4 mM deoxynucleotide triphosphates mixture, 2 U RNase inhibitor, 500 nM each primer, 300 nM probe, 1 l enzyme mix, i and RNase-free (diethyl pyrocarbonate treated) sterile H 2 O up to 25 l. The samples were then subjected to the following thermocycling conditions in a programmable thermal cycler: 30 min at 50 C; 15 min at 95 C; 40 cycles of 1 min at 94 C, 1 min at 55 C, and 2 min at 72 C; 7 min at 72 C; and hold at 4 C. At 45-50 cycles, false positives began to appear (known negatives which appear to be slightly positive), as determined using a detection system that discerns fluorescence in real time. j TaqMan analysis. All reactions were completed in 96well optical plates. h Plates containing incomplete reactions were preread at 518 nm (6-FAM) and 582 nm (TAMRA) on a sequence detector. k After the reactions were completed, the optical plates were postread at the same wavelengths. System software k normalized the reporter dye (6-FAM) against the passive reference dye (ROX) and calculated the R n , reflective of the level of probe hydrolysis. The degree of fluorescence due to probe hydrolysis (interpreted as the degree of amplification) was determined by calculating the ⌬ R n (the difference in the R n value before and after the PCR). The cutoff value was calculated from the following equation: 3 ϫ (SD of the nontemplate controls ϫ t) ϩ average nontemplate control value. The value t was provided by the sequence detection manufacturer. h IPMA. The IPMA was modified from a previously described method 10 for the standard procedure used at the MVDL. Twenty-five microliters of suspect serum sample was added to each well of a 96-well cell culture grade microtiter plate l (100 l/well) followed by the addition of 100 l of BT cell suspension (10 6 cells/ml). The plates were incubated for 4 days at 37 C in 5% CO 2 . After removal of the medium, the plates were air dried for 1 hr, fixed with 20% acetone in phosphate-buffered saline (PBS) for 10 min, and allowed to dry overnight at room temperature. The inoculated cells were rehydrated with 100 ml of binding buffer (0.5 M NaCl and 0.01% Tween 20 in PBS) and subsequently decanted. Fifty microliters of monoclonal antibody (mAb) mixture (1:1,000 dilution of mAb15.C.5 m and 1:2,000 dilu- tion of mAb21.10.6 m in binding buffer) was added to each well, and the plates were incubated for 1 hr at 37 C. After rinsing 3 times in PBS containing 0.05% Tween 20 (PBST, 100 l/well), the plates were incubated with 50 l/well of biotinylated rabbit anti-mouse antibodies n (1:500 dilution in binding buffer) containing 60% chicken serum for 1 hr at 37 C. Following 3 rinses in PBST, 50 l of a 1:500 dilution (in binding buffer) of horseradish peroxidase (HRP)-streptavidin n was added, and the plates were incubated for 1 hr at 37 C. The plates were again rinsed 3 times with 50 l of a solution containing 0.06% (w/v) AEC solution (20 mg 3amino-9-ethylcarbazole o dissolved in 4 ml dimethylsulfoxide o ). Then 0.012% (v/v) H 2 O 2 in 0.05 M sodium acetate buffer (pH 5.0) was added, and the plates were incubated in the dark for 10-40 min. The buffer was then decanted, and the plates were allowed to air dry. A positive reaction was characterized by the appearance of red cytoplasmic staining in at least 1 cluster of cells. The absence of the red precipitate indicated that the samples lacked BVDV. At least 1 positive control and 1 negative control were included on each plate.
IHC. Paraffin-embedded tissue sections were cut, placed on slides, deparaffinized, and rehydrated using routine methods. An HRP kit p was used for the immunoenzymatic/immunohistochemical staining of these tissues. Prepared tissue sections were treated with proteinase K q (20 mg/ml) in 0.05 M Tris-buffered saline (TBS), pH 7.6, at room temperature for 5 min and then rinsed in running tap water for 10 min. The sections were then rinsed in TBS containing 0.05% Tween 20 (TBST), pH 7.6, for 5 min. Tissue section slides were loaded into an autostainer q and processed as follows: 5-min rinse in TBST, 15-min block with endogenous peroxidase (3% H 2 O 2 /H 2 O, v/v), 5-min rinse in TBST, 10-min block of nonspecific binding sites with normal goat serum diluted 1:10 in TBS, 30-min incubation with anti-BVDV antibody (1:75 dilution of clone 15CF TCSN m ), 5-min rinse with TBST, 15-min incubation with biotinylated goat antirabbit and mouse IgG, p 5-min rinse with TBST, 15-min incubation with streptavidin-biotin-HRP, p 5-min rinse with TBST, 10-min detection of immunoreactivity with AEC, p and a final 5-min rinse in water. Slides were then removed from the apparatus and rinsed in running tap water for 5 min. Following a 2-5 min counterstain with Mayer's hematoxylin, o the slides were again rinsed with tap water. BVDV antigen is visualized by red staining produced by the reaction of the HRP with the H 2 O 2 /AEC complex.
VI. Both clinical tissue and serum samples submitted to the MVDL for detection of BVDV by MVDL standard VI were used in this study. Serum samples needed no processing before isolation was attempted. Tissue samples were placed in a prelabeled stomaching bag with enough liquid to produce 20% homogenates and homogenized in a stomacher. The liquid was then centrifuged at 3,600 ϫ g for 1 hr at 4 C. The supernatants were either stored at 4 C or used immediately to inoculate cells. BT cells for inoculation were grown to an 80% confluent monolayer on growth medium (minimum essential medium Eagle r containing 4% fetal horse serum) in 24-well plates. The growth medium was aspirated and 500 l of either serum or tissue supernatant was inoculated in duplicate onto the BT monolayer. Inocu-lated plates were then placed in a CO 2 incubator at 37 C for 1 hr. After incubation, the cells were washed with Hanks r solution 3 times before 1 ml of growth medium was added to each well, and the plates were returned to the CO 2 incubator. The plates were then observed daily for the presence of cytopathic effect (CPE) for 5-7 days postinoculation. When CPE was present and/or the incubation period was over, cells from 1 well of each sample were scraped and placed in a single well of a 10-well black ring slide and allowed to air dry. When dry, the slide was fixed in acetone for 10 min before adding BVDV fluorescien-labeled antibody. s The slide was then incubated in a moist chamber at 37 C for 30 min, rinsed in PBS for 5 min, counterstained in Evan blue for 1 min, and dipped in dionized water. The slide was observed for fluorescent staining using an ultraviolet light microscope at 400ϫ magnification. If staining of the cytoplasm was observed, the sample was considered positive for BVDV.
Results
BVDV TaqMan RT-PCR specificity. Ten clinical isolates of BVDV (3 type I and 7 type II) were tested by BVDV TaqManRT-PCR, and all were positive ( Table 1 ). The genotypically similar BDV, which causes border disease in sheep, was also positive by BVDV TaqMan RT-PCR (Table 1) . Bovine respiratory syncytial virus vaccine and the multivalent vaccine containing infectious bovine rhinotracheitis, parainfluenza virus type 3, and respiratory syncytial virus were both negative using this test ( Table 1) . Sources of other negative control viruses were difficult to identify because many such viruses were propagated in cells with medium containing fetal bovine serum, potentially con- taining BVDV genetic material that might be amplified by BVDV TaqMan RT-PCR.
Sensitivity of BVDV TaqMan RT-PCR test. BVDV (10 6 TCID 50 /ml, 76 g isolated BVDV RNA/ml) was diluted in 10-fold serial dilutions with fetal horse serum. Viral RNA was isolated from each dilution prior to analysis by TaqMan RT-PCR. As shown in Table  2 , the test detected as little as 10 TCID 50 /ml of BVDV, which correlates with detection of approximately 1 ng/ ml BVDV RNA. There are no estimates of diagnostic sensitivity for BVDV IPMA and IHC.
Comparison of BVDV TaqMan RT-PCR, VI, IPMA, and IHC. During the course of 1 year, 1,416 bovine serum samples submitted to the MVDL for BVDV VI and/or IPMA were analyzed simultaneously with BVDV TaqMan RT-PCR to compare the 3 diagnostic tests ( Table 3 , A-C). Both VI and IPMA results are included in this study as separate tests for several reasons. IPMA is used as a screening test for a larger number of samples than is VI. However, IPMA is less sensitive because it uses smaller samples and fewer cells. Although IPMA can only be used on serum samples, VI can be used on tissue, buffy coat, and serum. Therefore, samples were tested for BVDV usually with either IPMA or VI, depending on the sample type and the request of the pathologist or practitioner. For a total of 18 serum samples, the BVDV TaqMan RT-PCR results were positive and the VI and/or IPMA results were negative. No clinical histories were available to further evaluate the difference in results. However, the TaqMan RT-PCR would detect nonviable virus resulting from handling errors associated with collection and transport. It is also possible that these were false-positive reactions.
In the same manner, a comparison was done using 1,035 bovine tissues on which BVDV IHC and/or VI were performed simultaneously with TaqMan RT-PCR (Table 3 , D-F). Most BVDV TaqMan RT-PCR tissue samples are homogenates derived from a pool of tissues including lung, lymphoid tissue, heart, spleen, kidney, and intestine. Tissue selection for test-ing is determined by the pathologist and the submitting veterinarian. Eighty tissue samples that were BVDV TaqMan RT-PCR positive but IHC and/or VI negative were reviewed to compare RT-PCR findings with clinical history and microscopic lesions. Seventy-three of 80 tissue samples positive by BVDV TaqMan RT-PCR were associated with clinical histories and tissue lesions appropriate for the syndromes of BVDV infection, which include pneumonia, diarrhea, oral ulceration, failure to thrive, weak-born calves, abortion, and anemia. Seven tissue samples positive by BVDV TaqMan RT-PCR were associated with clinical histories of sudden unexpected death but did not have tissue lesions typical of BVDV infection. A cause of death in one animal was associated with cardiac fibrosis. A cause of death in 6 of the 7 animals was not determined. These 7 animals may represent transient or persistent BVDV infection, modified-live vaccine virus, or false-positive reactions. BVDV modified-live virus vaccine administration was rarely reported, and when given, the date of administration was not indicated. Both clinical histories and microscopic lesions support the positive BVDV TaqMan RT-PCR tissue results in 73 of 80 cases. Although there are no estimates of diagnostic sensitivity for IHC, TaqMan RT-PCR was able to detect very small quantities of BVDV RNA and may be better suited for identification of PI animals.
Discussion
Detection and elimination of calves and cows persistently infected with BVDV is a necessary step in controlling BVDV in cattle herds. To detect PI animals, buffy coat or serum samples from the entire herd or portions of a herd are tested to determine if any animal is infected with BVDV. Testing is accomplished by VI in cell culture followed by virus detection/identification by immunofluorescent antibody assay or IPMA. Diagnosis from tissues is done by VI, IHC, and histopathology. Although VI is a reliable technique, it takes several days for results to be available. Furthermore, nonviable and previously undetectable virus in routine diagnostic tissue samples is a concern for laboratory diagnosticians in all of these standard testing methods. Nucleic acid amplification by RT-PCR and RT followed by nested PCR have recently been employed and are considered to be sensitive and rapid. 1, 12 These gel-based RT-PCR methods, however, suffer from the disadvantage of potential contamination from tubes opened after amplification when an exponentially high amount of RT-PCR product may be present. This PCR product can subequently become the erroneous template for future RT-PCR reactions and create false-positive results. Gel-based methods also are labor intensive and time consuming, making it difficult to process a high number of samples. The results of the present study indicate that the closed, 1-tube technique is more sensitive than VI, IPMA, or IHC and easier to use, making it possible to run a large number of samples in a relatively easy and dependable manner.
One potential problem may occur when tissue samples are processed in diluent containing fetal bovine serum. Because most fetal bovine sera are known to be contaminated with live or inactivated BVDV, the TaqMan RT-PCR assay of these samples may yield false-positive results. During this study, it was difficult to obtain a variety of bovine isolates that were not contaminated with inactivated-BVDV present in fetal bovine serum. BT cells that were grown in medium containing fetal bovine serum tested positive in the BVDV TaqMan RT-PCR test, but the same cells grown in tandem in fetal horse serum did not. Cells initially grown in medium containing fetal bovine serum and then transferred to medium containing fetal horse serum tested positive for a few passages but became negative later on. Therefore, it is necessary to process bovine tissues using medium containing fetal horse serum to correctly identify BVDV in clinical samples using the TaqMan RT-PCR test.
The BVDV TaqMan RT-PCR will enable a labo-ratory to attain a more rapid, sensitive, and specific detection of BVDV infection. Routine use of such an RT-PCR test for virus antigen detection will enhance the diagnosis of disease, the understanding of epidemiology, and the evaluation of control programs. Likewise, traditional expectations and interpretations for evaluating BVDV infection may have to change, such as the use of VI as the gold standard for evaluating and adapting PCR amplification tests for routine diagnostic use. This advancement in veterinary diagnostic medicine will enable bovine practitioners to more easily identify and eliminate BVDV-infected cattle.
